Home/Thiogenesis Therapeutics/Christopher M. Starr, PhD
CM

Christopher M. Starr, PhD

Chairman, Board

Thiogenesis Therapeutics

Roles

Chairman, BoardatThiogenesis Therapeutics
Chief Operating OfficeratMonopar Therapeutics

Thiogenesis Therapeutics Pipeline

DrugIndicationPhase
TTI-0102Nephropathic CystinosisPhase 3 (planned)